<DOC>
	<DOCNO>NCT01653613</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor find good way treat cancer . PURPOSE : This laboratory study look gene sample young patient acute lymphoblastic leukemia ( ALL ) .</brief_summary>
	<brief_title>Studying Genes Samples From Younger Patients With Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To identify somatically acquire genetic copy number sequence alteration time diagnosis adolescent young adult ( AYA ) acute lymphoblastic leukemia ( ALL ) sample correlate clinical laboratory characteristic outcome . - To identify specific microarray multi-gene multi-exon expression signature time diagnosis correlate clinical laboratory characteristic outcome . - To gain insight genetic event contribute formation , development relapse AYA ALL integrate copy number sequence alteration multi-gene signature compare data already generate pediatric ALL . OUTLINE : Cryopreserved sample analyze DNA copy number alteration loss-of-heterozygosity , gene expression profiling , mutation analysis single nucleotide polymorphism ( SNP ) microarrays , Affymetrix Exon array , whole genome amplification ( WGA , Repli-G Qiagen ) . Confirmation study do fluorescence situ hybridization ( FISH ) , reverse transcriptase ( RT ) -polymerase chain reaction ( PCR ) , rapid amplification cDNA end ( RACE ) .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Samples patient diagnose Bprogenitor AYA ALL : The Children 's Oncology Group high risk ALL Study AALL0232 ( age 1621 ) The St. Jude Children 's Research Hospital ( SJCRH ) Total XV study ( age 1621 ) AYA ALL ( patient 2230 year age patient age 3139 year ) exist ALL Tissue Repositories adult National Cancer Institute ( NCI ) Cooperative Oncology Groups The Cancer Leukemia Group B ( CALGB ) The Eastern Cooperative Oncology Group ( ECOG ) The Southwest Oncology Group ( SWOG ) Cryopreserved viable leukemic cell suspension , obtain bone marrow peripheral blood pretreatment initial diagnosis Matched normal ( germline ) sample end inductionremission bone marrow blood sample buccal swab , available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>B-cell adult acute lymphoblastic leukemia</keyword>
	<keyword>B-cell childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
</DOC>